Search results
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 5 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 3 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 5 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna’s mRNA dreams meet reality with first post-Covid shot
Boston.com· 6 days agoModerna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 6 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...